How many employees does Inhibrx have this year?
Inhibrx has 91 undefined employees this year.
Inhibrx Employees 2024
Inhibrx Employees
91
Ticker
INBX
ISIN
US45720L1070
WKN
A2PQMH
In 2024, Inhibrx employed 91 people, a 0% change from the 91 number of employees in the previous year.
Inhibrx Aktienanalyse
What does Inhibrx do?
Inhibrx Inc is a biopharmaceutical company specializing in the development and commercialization of therapeutic antibodies. The company was founded in 2011 and is headquartered in La Jolla, California. Inhibrx's business model is based on the research and development of innovative antibodies targeting various diseases such as cancer, inflammation, autoimmune diseases, and infectious diseases. The company utilizes proprietary technologies and platforms to produce a wide range of antibodies that specifically target and block key proteins in the body. Inhibrx is divided into two business segments: the clinical development department and the research and development department. The clinical development department is responsible for conducting clinical trials of the company's antibodies. The research and development department is responsible for the development and refinement of new antibody platforms and technologies. Inhibrx has a number of products in the pipeline, including IRX-2, an antibody developed for the treatment of patients with solid tumor diseases. IRX-2 targets the PD-L1 and PD-L2 proteins, which are overexpressed by many cancer cells and help tumor cells evade immune defenses. In clinical studies, IRX-2 has shown significant reduction in tumor volume in many patients. Another promising product from Inhibrx is IRX-6, an antibody developed for the treatment of autoimmune diseases such as lupus and rheumatoid arthritis. IRX-6 targets the protein BAFF, which plays a key role in the activation of immune cells. Inhibrx has also partnered with pharmaceutical company Celgene Corporation to develop new cancer therapies. As part of the partnership, Inhibrx will utilize its proprietary antibody platforms and technologies to identify and develop new cancer therapies. Inhibrx has an excellent reputation in the industry and has been recognized multiple times for its innovative approaches and technologies. The company has secured a place among the leading biopharmaceutical companies and is expected to continue playing a significant role in the development of new therapies. Inhibrx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Inhibrx's Employee Base
Inhibrx's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Inhibrx's operational capacity and future potential.
Year-to-Year Comparison
Assessing Inhibrx's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Inhibrx's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Inhibrx’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Inhibrx stock
How many employees did Inhibrx have compared to the previous year?
Compared to the previous year, Inhibrx had 0% more employees.
What impact did the number of employees have on the company Inhibrx?
The number of employees has a direct impact on the efficiency and productivity of Inhibrx. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Inhibrx?
The number of employees can also have an impact on investors of Inhibrx, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Inhibrx affect the company?
An increase in equity of Inhibrx can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Inhibrx's equity affect the company?
A reduction in equity of Inhibrx can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Inhibrx?
Some factors that can influence the equity of Inhibrx include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Inhibrx so important for investors?
The equity of Inhibrx is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Inhibrx influence the company?
The number of employees at Inhibrx can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Inhibrx evolved in recent years?
In recent years, the number of employees at Inhibrx has changed by 0.
How many employees does Inhibrx currently have?
Inhibrx currently has 91 undefined employees.
Why is the number of employees important for investors of Inhibrx?
The number of employees is important for investors of Inhibrx as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Inhibrx take to change the number of employees?
To change the number of employees, Inhibrx can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Inhibrx pay?
Over the past 12 months, Inhibrx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inhibrx is expected to pay a dividend of 0 USD.
What is the dividend yield of Inhibrx?
The current dividend yield of Inhibrx is .
When does Inhibrx pay dividends?
Inhibrx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inhibrx?
Inhibrx paid dividends every year for the past 0 years.
What is the dividend of Inhibrx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inhibrx located?
Inhibrx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inhibrx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inhibrx from 11/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/27/2024.
When did Inhibrx pay the last dividend?
The last dividend was paid out on 11/27/2024.
What was the dividend of Inhibrx in the year 2023?
In the year 2023, Inhibrx distributed 0 USD as dividends.
In which currency does Inhibrx pay out the dividend?
The dividends of Inhibrx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inhibrx
Our stock analysis for Inhibrx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inhibrx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
